90 related articles for article (PubMed ID: 25696931)
21. The diagnostic value of serum carcino-embryonic antigen, alpha fetoprotein and carbohydrate antigen 19-9 for colorectal cancer.
Wang YR; Yan JX; Wang LN
J Cancer Res Ther; 2014 Dec; 10 Suppl():307-9. PubMed ID: 25693941
[TBL] [Abstract][Full Text] [Related]
22. A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
Chang YT; Huang MY; Yeh YS; Huang CW; Tsai HL; Cheng TL; Wang JY
PLoS One; 2016; 11(10):e0163264. PubMed ID: 27701415
[TBL] [Abstract][Full Text] [Related]
23. Bead-based microarray immunoassay for lung cancer biomarkers using quantum dots as labels.
Liu L; Wu S; Jing F; Zhou H; Jia C; Li G; Cong H; Jin Q; Zhao J
Biosens Bioelectron; 2016 Jun; 80():300-306. PubMed ID: 26852198
[TBL] [Abstract][Full Text] [Related]
24. Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer.
Liu F; Du F; Chen X
World J Surg Oncol; 2014 Nov; 12():333. PubMed ID: 25381564
[TBL] [Abstract][Full Text] [Related]
25. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
Iarŭmov N; Ignatov A; Viiachki I
Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
[TBL] [Abstract][Full Text] [Related]
26. [Clinical usefulness of circulating tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
[TBL] [Abstract][Full Text] [Related]
27. Circulating antibodies to carcinoembryonic antigen related to improved recurrence-free survival of patients with colorectal carcinoma.
Wu XJ; Fang YJ; Lin JZ; Lu ZH; Li LR; Chen G; Ding PR; Kong LH; Pan ZZ; Wan DS
J Int Med Res; 2011; 39(3):838-45. PubMed ID: 21819716
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B
Int J Colorectal Dis; 2007 Jan; 22(1):33-8. PubMed ID: 16520929
[TBL] [Abstract][Full Text] [Related]
29. Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Giessen-Jung C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Schulz C; Heinemann V; Di Gioia D; Stieber P
Tumour Biol; 2015 Sep; 36(10):7897-906. PubMed ID: 25953265
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
Liu C; Ma H; Qu L; Wu J; Meng L; Shou C
Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous detection of seven staphylococcal enterotoxins: development of hydrogel biochips for analytical and practical application.
Rubina AY; Filippova MA; Feizkhanova GU; Shepeliakovskaya AO; Sidina EI; Boziev KhM; Laman AG; Brovko FA; Vertiev YV; Zasedatelev AS; Grishin EV
Anal Chem; 2010 Nov; 82(21):8881-9. PubMed ID: 20843007
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic cytokines in the sera of patients with pancreatic cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Jurkowska G
Clin Chem Lab Med; 2005; 43(2):146-50. PubMed ID: 15843207
[TBL] [Abstract][Full Text] [Related]
33. Models of logistic regression analysis, support vector machine, and back-propagation neural network based on serum tumor markers in colorectal cancer diagnosis.
Zhang B; Liang XL; Gao HY; Ye LS; Wang YG
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323037
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of predictive markers for patients with advanced colorectal cancer.
Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B
Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092
[TBL] [Abstract][Full Text] [Related]
35. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
36. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic relevance of a novel multiplex immunoassay panel in breast cancer.
Hermann N; Dressen K; Schroeder L; Debald M; Schildberg FA; Walgenbach-Bruenagel G; Hettwer K; Uhlig S; Kuhn W; Hartmann G; Holdenrieder S
Tumour Biol; 2017 Jun; 39(6):1010428317711381. PubMed ID: 28618926
[TBL] [Abstract][Full Text] [Related]
38. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous multianalyte immunoassay measurement of five serum tumor markers in the detection of colorectal cancer.
Lumachi F; Marino F; Orlando R; Chiara GB; Basso SM
Anticancer Res; 2012 Mar; 32(3):985-8. PubMed ID: 22399621
[TBL] [Abstract][Full Text] [Related]
40. Hybrid hydrogel photonic barcodes for multiplex detection of tumor markers.
Xu Y; Zhang X; Luan C; Wang H; Chen B; Zhao Y
Biosens Bioelectron; 2017 Jan; 87():264-270. PubMed ID: 27567252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
